The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

NEUROLOGY

LIPPINCOTT WILLIAMS & WILKINS

1. Dutch MS Research Foundation [13-820]
2. Amsterdam Neuroscience
3. UK MS Society Rosetrees
4. National MS Society
5. PMSA Trust
6. National Institute for Health Research, University College London Hospitals Biomedical Research Centre